IS4459A - Ný peptíð er hafa ónæmisbreytandi áhrif - Google Patents

Ný peptíð er hafa ónæmisbreytandi áhrif

Info

Publication number
IS4459A
IS4459A IS4459A IS4459A IS4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A IS 4459 A IS4459 A IS 4459A
Authority
IS
Iceland
Prior art keywords
immune
modifying
new peptides
peptides
new
Prior art date
Application number
IS4459A
Other languages
English (en)
Inventor
Bergstrand Håkan
Eriksson Tomas
Karabelas Kostas
Lindvall Magnus
Särnstrand Bengt
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4459A publication Critical patent/IS4459A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IS4459A 1994-10-14 1997-04-08 Ný peptíð er hafa ónæmisbreytandi áhrif IS4459A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9403526A SE9403526D0 (sv) 1994-10-14 1994-10-14 New Peptides
PCT/SE1995/001151 WO1996011943A1 (en) 1994-10-14 1995-10-06 New peptides with immunomodulatory effects

Publications (1)

Publication Number Publication Date
IS4459A true IS4459A (is) 1997-04-08

Family

ID=20395628

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4459A IS4459A (is) 1994-10-14 1997-04-08 Ný peptíð er hafa ónæmisbreytandi áhrif

Country Status (20)

Country Link
US (2) US6103697A (is)
EP (1) EP0783519A1 (is)
JP (1) JPH10507448A (is)
AU (1) AU705364B2 (is)
BR (1) BR9509345A (is)
CA (1) CA2201479A1 (is)
CZ (1) CZ111997A3 (is)
EE (1) EE9700087A (is)
FI (1) FI971499A7 (is)
HU (1) HUT77118A (is)
IL (1) IL115509A0 (is)
IS (1) IS4459A (is)
MX (1) MX9702666A (is)
NO (1) NO971625L (is)
PL (1) PL319631A1 (is)
SE (1) SE9403526D0 (is)
SK (1) SK46797A3 (is)
TR (1) TR199501255A2 (is)
WO (1) WO1996011943A1 (is)
ZA (1) ZA958140B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides
SE9501067D0 (sv) 1995-03-24 1995-03-24 Astra Ab New peptides
WO1997039023A1 (en) * 1996-04-12 1997-10-23 Astra Aktiebolag Cysteine-containing or methioine-containing peptides with immunomodulatory effects
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンaエーロゾル溶液処方物
SE9603462D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603465D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603466D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603463D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603461D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603468D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
SE9603467D0 (sv) * 1996-09-23 1996-09-23 Astra Ab New compounds
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
AU9655698A (en) * 1997-10-10 1999-05-03 Astra Aktiebolag Synthetic genes with immunomodulatory effects
EP1083872A1 (en) * 1998-06-03 2001-03-21 GPI NIL Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
RU2144374C1 (ru) * 1998-11-23 2000-01-20 Закрытое акционерное общество "ВАМ" Способ получения композита окисленного глутатиона с cis-диаминодихлорплатиной и фармацевтических композиций на его основе, регулирующих метаболизм, пролиферацию, дифференцировку и механизмы апоптоза нормальных и трансформированных клеток
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US7265208B2 (en) * 2001-05-01 2007-09-04 The Regents Of The University Of California Fusion molecules and treatment of IgE-mediated allergic diseases
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
CA2632353C (en) 2005-04-25 2018-02-20 Bakulesh Mafatlal Khamar Vaccine adjuvants comprising mycobaterium
KR101363455B1 (ko) 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
JPH01501939A (ja) 1987-01-28 1989-07-06 オーソ・フアーマシユーチカル・コーポレーシヨン 免疫抑制ペプチドおよび使用法
FR2622700B1 (fr) 1987-10-30 1993-08-13 Aderegem Proteine et ses fragments representant l'expression specifique du gene ps2 des cancers du sein, anticorps obtenus a partir de ladite proteine et/ou de ses fragments, leurs applications a la detection et au diagnostic de cancers du sein
WO1989010935A1 (en) * 1988-05-09 1989-11-16 Abbott Laboratories Atrial peptide derivatives
US5223485A (en) * 1989-01-31 1993-06-29 Abbott Laboratories Anaphylatoxin-receptor ligands
JP2596466B2 (ja) 1990-03-03 1997-04-02 アサヒビール株式会社 ダニの主要アレルゲンの還伝情報を有するdnaおよび該アレルゲンの製造方法
ATE178940T1 (de) 1990-09-11 1999-04-15 Inst Child Health Research Klonierung und sequenzierung von dermatophagoiden-antigenen (hausstaubmilben)
AU2296792A (en) * 1991-06-28 1993-01-25 Corvas International, Inc. Novel inhibitors of platelet aggregation
JP2657861B2 (ja) 1991-09-17 1997-09-30 アサヒビール株式会社 ダニ主要アレルゲンの製造方法
HU220462B1 (hu) 1991-10-16 2002-02-28 Immulogic Pharmaceutical Corp. A Dermatophagoides nemzetség allergénjéből származó peptidek, ezeket tartalmazó gyógyszerkészítmények és eljárás házi poratka-érzékenység kimutatására
JP3149033B2 (ja) 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンDer f II中のペプチド
SG49008A1 (en) 1993-03-05 1998-05-18 Cytel Corp Hla-a2.1 binding peptides and their uses
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
JPH07215996A (ja) 1994-01-31 1995-08-15 Torii Yakuhin Kk ダニアレルゲンのb細胞エピトープ
MX9606537A (es) 1994-07-05 1997-12-31 Steeno Res Group As Inmunomoduladores.
SE9403526D0 (sv) 1994-10-14 1994-10-14 Astra Ab New Peptides

Also Published As

Publication number Publication date
FI971499L (fi) 1997-06-10
NO971625D0 (no) 1997-04-09
AU705364B2 (en) 1999-05-20
HUT77118A (hu) 1998-03-02
TR199501255A2 (tr) 1996-06-21
WO1996011943A1 (en) 1996-04-25
EP0783519A1 (en) 1997-07-16
MX9702666A (es) 1997-06-28
EE9700087A (et) 1997-10-15
CZ111997A3 (en) 1997-12-17
AU3713395A (en) 1996-05-06
CA2201479A1 (en) 1996-04-25
US6228374B1 (en) 2001-05-08
US6103697A (en) 2000-08-15
BR9509345A (pt) 1997-11-25
ZA958140B (en) 1997-06-27
SE9403526D0 (sv) 1994-10-14
FI971499A0 (fi) 1997-04-10
SK46797A3 (en) 1997-09-10
NO971625L (no) 1997-05-30
IL115509A0 (en) 1996-05-14
JPH10507448A (ja) 1998-07-21
FI971499A7 (fi) 1997-06-10
PL319631A1 (en) 1997-08-18

Similar Documents

Publication Publication Date Title
FI965225A7 (fi) Uusia peptidejä
FI961350A7 (fi) Hapteenimerkityt peptidit
FI972312L (fi) Uusia siiliperäisiä polypeptidejä
FI972194A7 (fi) Uusia bentsyylipyrimidiinejä
ATA166795A (de) Bis-resorcinyltriazine
ATA147195A (de) Alkoxyphenyl-substituierte bisbenzoylphosphinoxide
ATA163695A (de) 2-hydroxyphenyltriazine
FI954147L (fi) Polypeptidejä
NO985680L (no) Peptidderivater
FI953302A7 (fi) Uudet peptidit
FI953710L (fi) Uusia pyrrolokarbatsoleja
FI970168L (fi) Peptidejä
NO983849L (no) Peptidderivater
FI964363L (fi) Peptidejä
ATA108995A (de) Differenzdruckakkumulator
FI972215L (fi) Uusia polypeptidejä
TR199701666A3 (tr) Sismanliga karsi proteinler
FI963568A7 (fi) Peptidijohdannaisia
FI970744A7 (fi) Uusia immuuniehkäiseviä peptidejä
ATA11894A (de) Stauförderbahn
FIU940170U0 (fi) Stoedram
KR950024232U (ko) 개량 권련 케이스
KR950032123U (ko) 개량목탁
KR960003039U (ko) 개선된 파마로이
FI1360U1 (fi) Justerbar inpassningsdetalj